The MMedSci Oncology at Keele has been specifically designed to enable an introduction to a research programme whilst offering sustained clinical interaction throughout the course. Keele University
has a strong track record of clinically translational research, enabled by the close interaction of clinical interventionists with world leading academic researchers. This course benefits entirely from this bench-to-bedside ethos and will support like-minded students across this multidisciplinary environment. The course should serve as a platform to develop a medical research career.
As would be expected from such a clinically involved course, much of the teaching takes place at Keele University
’s hospital campus located in the Royal Stoke University Hospital, University Hospital of North Midlands (UHNM) Trust. Keele University
’s flagship research Institute for Science and Technology in Medicine (ISTM) is integrated with the hospital with the strategically aligned Guy Hilton Research Centre being located directly adjacent to the hospital. Being opened in 2006, this research centre offers patient treatment alongside state-of-the-art equipment and translational research. The centre has enabled research active clinical members to drive cutting-edge research and streamline the pipeline to patient benefit. The Oncology Department located in UHNM provides chemotherapy, radiotherapy, brachytherapy, clinical trials, and lymphoedema and haematology/oncology outpatients to a population of approximately 845,000. It is one of the top ten performing Trusts in the UK for delivering Intensity Modulated Radiotherapy (IMRT). This course offers the opportunity to interact closely with both clinical and research environments, with theoretical, practical and research-centric approaches underpinning the delivery of taught modules, clinical attachments and research projects.
Advances in the management of oncological patients are much needed in our rapidly aging community. New methods are continually being introduced allowing clinicians to better understand and react to patient care in an effort to maximise patient benefit and minimise in-patient time and treatment side effects. The MMedSci Oncology course offers the opportunity to harness the capabilities of cutting edge research to drive new concepts in a clinically transformative capacity.
The course has been awarded 50 CPD credits by the Royal College of Radiologists.
See the website https://www.keele.ac.uk/pgtcourses/medicalscienceoncology/
MMedSci Oncology draws together the fundamental principles of current oncological patient management, clinical practice, stem cell and pathology techniques for clinical assessment of tissue and biological samples, with a focus on research-driven work closely related to ‘real world’ clinical practice. Further, transferable skills are delivered through intensive Clinical Audit, Health Informatics, and Leadership & Management modules. The course is open to third year medical students and above, qualified doctors and qualified health professionals with an interest in Oncology.
The course is structured to sit within the framework of Keele University
’s MMedSci route, with module timescales allowing, if necessary, to be taken full-time within the one year of entry. The structure has been specifically designed to maximise both clinical engagement, support from taught components and research experience. The course is split between non-optional core modules that students must take to progress on the MMedSci Oncology route, with at least 4 of the elective modules as listed below.
Non Optional Core Modules (60 credits + 60 credit dissertation)
- Independent Practice-based Study (30 credits)
- Management of the Oncological Patient (15 credits)
- Experimental Research Methods (15 credits)
- Dissertation (60 credits)
Choice of Four Optional Modules (60 credits)
(subject to availability)
- Clinical Audit (15 credits)
- Health Informatics (15 credits)
- Contemporary Issues in Healthcare Ethics and Law (15 credits)
- Statistics and Epidemiology (15 credits)
- Introduction to Medical Imaging (15 credits)
- Cell and Tissue Engineering (15 credits)
- Stem Cells: Types, Characteristics and Applications (15 credits)
- Molecular Techniques: Applications in Tissue Engineering (15 credits)
Teaching & Assessment
All content is delivered from leaders in representative fields, either from academic staff in the University, or from active clinical staff in the National Health Service. Course content will develop students’ fundamental knowledge of the diagnosis and management of oncological patients. An appreciation regarding patient informed consent and establishment/ delivery of clinical trials is also covered alongside Research Methods, accumulating to a 6 month research project. Students will attend clinical seminars, multidisciplinary and mortality meetings within the UHNM Oncology Department to sustain engagement of the clinical delivery of topics taught throughout the course.
Students will be immersed in the clinical environment focussed on oncological management, with an emphasis on research procedures and translation of cutting-edge research into the clinic.
Assessment will be carried out by attending clinics, lectures and meetings, presentation of a patient case report, and a written assignment linked to the research project.
Apart from additional costs for text books, inter-library loans and potential overdue library fines we do not anticipate any additional costs for this postgraduate programme.
Find information on Scholarships here - http://www.keele.ac.uk/studentfunding/bursariesscholarships/
The course is open to third year medical students and above, qualified doctors and qualified health professionals with an interest in Oncology.